In addition, decreased cardiac HAMP expression has been reported in a transgenic mouse model of dilated cardiomyopathy, where the phenotype was ameliorated following transgenic overexpression of cardiac hepcidin (Zhang et al., 2012). Here, HAMP is linked to dilated cardiomyopathy.